Traumatic Flap Complications After Femtosecond LASIK
Purpose:
The purpose of this article was to evaluate the prognosis of traumatic flap dislocation or avulsion in a large series of laser-assisted in situ keratomileusis (LASIK) cases.
Methods:
Retrospective, consecutive, noncomparative case series analyzes the visual and anatomical results after flap dislocation or avulsion, caused by trauma occurred at least 1 month after LASIK.
Results:
A total of 37,315 eyes of 19,602 patients were reviewed. A traumatic flap complication was observed in 9 eyes of 9 patients, with a maximum interval of 37 months after surgery. Flap dislocation with central full-thickness...
Source: Cornea - April 11, 2022 Category: Opthalmology Tags: Clinical Science Source Type: research
Central Toxic Keratopathy in Siblings After Laser-Assisted Keratomileusis: Case Report and Literature Review
Conclusions:
CTK is a rare, noninflammatory but potentially sight-threatening entity most commonly associated with excimer laser ablation procedures. Its pathophysiology is poorly understood but likely multifactorial. Its isolated presentation in this case of 2 siblings suggests a possible underlying genetic predisposition, which has not been previously described. With careful monitoring and early supportive treatment, patients can have a complete and rapid resolution. (Source: Cornea)
Source: Cornea - April 11, 2022 Category: Opthalmology Tags: Case Report Source Type: research
Effectiveness and Safety of Adalimumab, Etanercept and Ustekinumab for Severe Psoriasis in Children Under 12 Years of Age: A French-Italian Daily Practice Cohort (BiPe Jr)
The objective of the 'BiPe Jr' cohort study was to evaluate the drug survival, effectiveness, tolerance and switching patterns of biological therapies in children under 12 years of age with psoriasis.METHODS: We conducted a multicentre retrospective study of children with psoriasis who received at least one injection of a biological agent, even off-licence, before the age of 12 years in France and Italy, collecting the data between April and August 2021. The data collected were from March 2012 up to August 2021.RESULTS: In total, 82 children (mean age: 9.1 years; females: 61.0%) received 106 treatments. The drugs administe...
Source: Paediatric Drugs - April 10, 2022 Category: Pediatrics Authors: Jinane Zitouni Alain Beauchet Rapha ëlle Curmin Vito Di Lernia Anne-Claire Bursztejn Juliette Mazereeuw-Hautier J érémy Gottlieb Audrey Lasek H élène Aubert Catherine Droitcourt Cristina Bulai-Livideanu Anna Belloni Fortina Francesca Caroppo Nathalie Source Type: research
Effectiveness and Safety of Adalimumab, Etanercept and Ustekinumab for Severe Psoriasis in Children Under 12 Years of Age: A French-Italian Daily Practice Cohort (BiPe Jr)
The objective of the 'BiPe Jr' cohort study was to evaluate the drug survival, effectiveness, tolerance and switching patterns of biological therapies in children under 12 years of age with psoriasis.METHODS: We conducted a multicentre retrospective study of children with psoriasis who received at least one injection of a biological agent, even off-licence, before the age of 12 years in France and Italy, collecting the data between April and August 2021. The data collected were from March 2012 up to August 2021.RESULTS: In total, 82 children (mean age: 9.1 years; females: 61.0%) received 106 treatments. The drugs administe...
Source: Paediatric Drugs - April 10, 2022 Category: Pediatrics Authors: Jinane Zitouni Alain Beauchet Rapha ëlle Curmin Vito Di Lernia Anne-Claire Bursztejn Juliette Mazereeuw-Hautier J érémy Gottlieb Audrey Lasek H élène Aubert Catherine Droitcourt Cristina Bulai-Livideanu Anna Belloni Fortina Francesca Caroppo Nathalie Source Type: research
Effectiveness and Safety of Adalimumab, Etanercept and Ustekinumab for Severe Psoriasis in Children Under 12 Years of Age: A French-Italian Daily Practice Cohort (BiPe Jr)
The objective of the 'BiPe Jr' cohort study was to evaluate the drug survival, effectiveness, tolerance and switching patterns of biological therapies in children under 12 years of age with psoriasis.METHODS: We conducted a multicentre retrospective study of children with psoriasis who received at least one injection of a biological agent, even off-licence, before the age of 12 years in France and Italy, collecting the data between April and August 2021. The data collected were from March 2012 up to August 2021.RESULTS: In total, 82 children (mean age: 9.1 years; females: 61.0%) received 106 treatments. The drugs administe...
Source: Paediatric Drugs - April 10, 2022 Category: Pediatrics Authors: Jinane Zitouni Alain Beauchet Rapha ëlle Curmin Vito Di Lernia Anne-Claire Bursztejn Juliette Mazereeuw-Hautier J érémy Gottlieb Audrey Lasek H élène Aubert Catherine Droitcourt Cristina Bulai-Livideanu Anna Belloni Fortina Francesca Caroppo Nathalie Source Type: research
